Although IL-1β has an established role in pathophysiology of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) [19], studies on changes in IL-1β levels in patients with SIBO are rare. This evidence concerns the gene IL1B and irritable bowel syndrome.